{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:18:10Z","timestamp":1771571890156,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000139","name":"U.S. Environmental Protection Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007824","name":"American Chemistry Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013521","name":"Cosmetic Surgery Foundation","doi-asserted-by":"publisher","award":["v3.3"],"award-info":[{"award-number":["v3.3"]}],"id":[{"id":"10.13039\/100013521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.yrtph.2023.105521","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T23:08:11Z","timestamp":1697670491000},"page":"105521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Derivation of oral cancer slope factors for hexavalent chromium informed by pharmacokinetic models and in vivo genotoxicity data"],"prefix":"10.1016","volume":"145","author":[{"given":"Chad M.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Kirman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yrtph.2023.105521_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14252\/foodsafetyfscj.2018014","article-title":"Mutant frequency is not increased in mice orally exposed to sodium dichromate","volume":"7","author":"Aoki","year":"2019","journal-title":"Food Safety"},{"issue":"8","key":"10.1016\/j.yrtph.2023.105521_bib2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/10408444.2020.1823934","article-title":"An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet","volume":"50","author":"Bhat","year":"2020","journal-title":"Crit. Rev. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2023.105521_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/em.22517","article-title":"Establishing a quantitative framework for regulatory interpretation of genetic toxicity dose-response data: margin of exposure case study of 48 compounds with both in vivo mutagenicity and carcinogenicity dose-response data","volume":"64","author":"Chepelev","year":"2023","journal-title":"Environ. Mol. Mutagen."},{"issue":"10","key":"10.1016\/j.yrtph.2023.105521_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/096032719601501001","article-title":"The linearized multistage model and the future of quantitative risk assessment","volume":"15","author":"Crump","year":"1996","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.yrtph.2023.105521_bib5","series-title":"Peer Review Workshop for Epa's Draft Toxicological Review of Hexavalent Chromium","year":"2011"},{"issue":"2","key":"10.1016\/j.yrtph.2023.105521_bib6","first-page":"56","article-title":"Risk assessment report hexavalent chromium (beverages)","volume":"7","year":"2019","journal-title":"Food Safety Commission of Japan"},{"key":"10.1016\/j.yrtph.2023.105521_bib7","series-title":"Water and Air Quality Bureau HEaCSB","article-title":"Guidelines for canadian drinking water quality: Guideline technical document \u2014 chromium","year":"2016"},{"issue":"1","key":"10.1016\/j.yrtph.2023.105521_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/em.22338","article-title":"Mutation as a toxicological endpoint for regulatory decision-making","volume":"61","author":"Heflich","year":"2020","journal-title":"Environ. Mol. Mutagen."},{"issue":"8","key":"10.1016\/j.yrtph.2023.105521_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/em.21870","article-title":"Derivation of point of departure (pod) estimates in genetic toxicology studies and their potential applications in risk assessment","volume":"55","author":"Johnson","year":"2014","journal-title":"Environ. Mol. Mutagen."},{"issue":"1","key":"10.1016\/j.yrtph.2023.105521_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cbi.2013.04.003","article-title":"Physiologically based pharmacokinetic model for humans orally exposed to chromium","volume":"204","author":"Kirman","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.yrtph.2023.105521_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cbi.2012.08.016","article-title":"Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium","volume":"200","author":"Kirman","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.yrtph.2023.105521_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.taap.2016.07.002","article-title":"Reduction of hexavalent chromium by fasted and fed human gastric fluid. Ii. Ex vivo gastric reduction modeling","volume":"306","author":"Kirman","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2023.105521_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.taap.2017.03.023","article-title":"Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populations","volume":"325","author":"Kirman","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.yrtph.2023.105521_bib14","first-page":"232","article-title":"Chronic toxicity studies. Ii. Hexavalent and trivalent chromium administered in drinking water to rats","volume":"18","author":"Mackenzie","year":"1958","journal-title":"AMA Arch Ind Health"},{"key":"10.1016\/j.yrtph.2023.105521_bib15","series-title":"National Toxicology Program Technical Report on the Toxicology and Carcinogenesis Studies of Sodium Dichromate Dihydrate (Cas No. 7789-12-0) in F344\/n Rats and B6c3f1 Mice (Drinking Water Studies), Ntp Tr 546","year":"2008"},{"issue":"1\u20132","key":"10.1016\/j.yrtph.2023.105521_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mrgentox.2013.03.008","article-title":"Assessment of k-ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to cr(vi) in drinking water","volume":"754","author":"O'Brien","year":"2013","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2023.105521_bib17","series-title":"Test Guideline No. 488, - Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays","year":"2022"},{"issue":"5","key":"10.1016\/j.yrtph.2023.105521_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.chemosphere.2012.04.065","article-title":"Hexavalent chromium reduction kinetics in rodent stomach contents","volume":"89","author":"Proctor","year":"2012","journal-title":"Chemosphere"},{"key":"10.1016\/j.yrtph.2023.105521_bib19","first-page":"E310","article-title":"Total chromium and hexavalent chromium occurrence analysis","volume":"105","author":"Seidel","year":"2013","journal-title":"J. Am. Waterworks Assoc."},{"key":"10.1016\/j.yrtph.2023.105521_bib20","series-title":"Hexavalent Chromium Oral Reference Dose: Development Support Document","year":"2016"},{"issue":"10","key":"10.1016\/j.yrtph.2023.105521_bib21","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1080\/10408444.2021.2000934","article-title":"A review of mammalian in vivo genotoxicity of hexavalent chromium: implications for oral carcinogenicity risk assessment","volume":"51","author":"Thompson","year":"2021","journal-title":"Crit. Rev. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2023.105521_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/toxsci\/kfq320","article-title":"Application of the u.S. Epa mode of action framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium","volume":"119","author":"Thompson","year":"2011","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.yrtph.2023.105521_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jat.3545","article-title":"Integration of mechanistic and pharmacokinetic information to derive oral reference dose and margin-of-exposure values for hexavalent chromium","volume":"38","author":"Thompson","year":"2018","journal-title":"J. Appl. Toxicol."},{"issue":"5","key":"10.1016\/j.yrtph.2023.105521_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jat.2907","article-title":"A chronic oral reference dose for hexavalent chromium-induced intestinal cancer","volume":"34","author":"Thompson","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2023.105521_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/em.22537","volume":"64","author":"Thompson","year":"2023","journal-title":"Environ. Mol. Mutagen"},{"issue":"1","key":"10.1016\/j.yrtph.2023.105521_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/toxsci\/kfr164","article-title":"Investigation of the mode of action underlying the tumorigenic response induced in b6c3f1 mice exposed orally to hexavalent chromium","volume":"123","author":"Thompson","year":"2011","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.yrtph.2023.105521_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/10408444.2013.768596","article-title":"Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans","volume":"43","author":"Thompson","year":"2013","journal-title":"Crit. Rev. Toxicol."},{"issue":"9","key":"10.1016\/j.yrtph.2023.105521_bib28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/em.22064","article-title":"Transcriptomic responses in the oral cavity of f344 rats and b6c3f1 mice following exposure to cr(vi): implications for risk assessment","volume":"57","author":"Thompson","year":"2016","journal-title":"Environ. Mol. Mutagen."},{"issue":"1","key":"10.1016\/j.yrtph.2023.105521_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/toxsci\/kfu206","article-title":"Synchrotron-based imaging of chromium and gamma-h2ax immunostaining in the duodenum following repeated exposure to cr(vi) in drinking water","volume":"143","author":"Thompson","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2023.105521_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mrgentox.2017.08.004","article-title":"Ten factors for considering the mode of action of cr(vi)-induced gastrointestinal tumors in rodents","volume":"823","author":"Thompson","year":"2017","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yrtph.2023.105521_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mrgentox.2015.05.004","article-title":"Duodenal crypt health following exposure to cr(vi): micronucleus scoring, gamma-h2ax immunostaining, and synchrotron x-ray fluorescence microscopy","volume":"789\u2013790","author":"Thompson","year":"2015","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen"},{"issue":"7","key":"10.1016\/j.yrtph.2023.105521_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/em.21952","article-title":"Assessment of the mutagenic potential of cr(vi) in the oral mucosa of big blue((r)) transgenic f344 rats","volume":"56","author":"Thompson","year":"2015","journal-title":"Environ. Mol. Mutagen."},{"issue":"8","key":"10.1016\/j.yrtph.2023.105521_bib33","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jat.1621","article-title":"The expression of rkip, rhogdi, galectin, c-myc and p53 in gastrointestinal system of cr(vi)-exposed rats","volume":"31","author":"Tsao","year":"2011","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2023.105521_bib34","series-title":"Guidelines for Carcinogen Risk Assessment, Epa\/630\/p-03\/001f","year":"2005"},{"key":"10.1016\/j.yrtph.2023.105521_bib35","series-title":"Toxicological Review of Hexavalent Chromium in Support of Summary Information on the Integrated Risk Information System (Iris). External Review Draft","year":"2010"},{"key":"10.1016\/j.yrtph.2023.105521_bib36","series-title":"Benchmark Dose Technical Guidance. Risk Assessment Forum","year":"2012"},{"key":"10.1016\/j.yrtph.2023.105521_bib37","series-title":"Data Summary of the Third Unregulated Contaminant Monitoring Rule (Ucmr3)","year":"2017"},{"key":"10.1016\/j.yrtph.2023.105521_bib38","series-title":"Iris Toxicological Review of Hexavalent Chromium","year":"2022"},{"issue":"1","key":"10.1016\/j.yrtph.2023.105521_bib39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/em.22351","article-title":"Quantitative interpretation of genetic toxicity dose-response data for risk assessment and regulatory decision-making: current status and emerging priorities","volume":"61","author":"White","year":"2020","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.yrtph.2023.105521_bib40","series-title":"Chromium in Drinking Water: Background Document for Development of Who Guidelines for Drinking-Water Quality","year":"2020"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230023001897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230023001897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:36:14Z","timestamp":1759494974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230023001897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":40,"alternative-id":["S0273230023001897"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2023.105521","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Derivation of oral cancer slope factors for hexavalent chromium informed by pharmacokinetic models and in vivo genotoxicity data","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2023.105521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105521"}}